News from Health
Berries blamed for California man's Hepatitis A
ENCINITAS, Calif. -- Geoff Soza was celebrating his 30th wedding anniversary in Yellowstone National Park when the 64-year-old man learned the hard way that his seemingly healthy breakfast habit of mixing thawed berries with Greek yogurt had exposed him
Alliance Pharma buys rights to Novartis' obstetric drug Syntometrine
(Reuters) - Specialty pharmaceutical company Alliance Pharma Plc said it bought all existing rights to obstetric drug Syntometrine from Novartis AG for $11.5 million. Alliance Pharma, which acquires, markets and distributes pharmaceutical products, alrea
Endo Health to slash 15 percent jobs, looks to sell some assets
(Reuters) - Endo Health Solutions Inc said it plans to cut about 15 percent of its workforce and explore strategic alternatives for some assets as the company looks to cut costs ahead of generic competition for two of its biggest drugs. The company's chi
Pennsylvania girl eligible for adult organ donation after ruling
NEW YORK (Reuters) - A 10-year old girl with cystic fibrosis who had been kept off an adult organ transplant list due to an age-restriction rule will now be eligible for an adult lung transplant, a federal judge in Pennsylvania ruled on Wednesday. The fa
Judge rules in favor of Pa. girl who needs lung
PHILADELPHIA -- A federal judge in Philadelphia has made a dying 10-year-old eligible to seek donor lungs from an adult transplant list. U.S. District Judge Michael Baylson says he is granting the temporary request because of the severity of Sarah Murnag
Group therapy helps rape victims in poor countries
NEW YORK (Reuters Health) - Group therapy works better than individual support for women in low-income countries who have been victims of sexual violence, according to the results of a new study done in the Democratic Republic of Congo (DRC). The method
Few access Internet help for colonoscopy prep
NEW YORK (Reuters Health) - Despite reminders, people scheduled for a colonoscopy didn't access an Internet video designed to educate them about proper preparation for the screening, in a new study. "We were really surprised. It wasn't just that...
Mexico finds breast-feeding woes as rate drops
MEXICO CITY -- Despite the well-known advantages to breast milk and vigorous campaigns around the world championing breast as best, Mexican mothers say the bottle is better. In a dramatic decline over the past six years, today only one in seven mothers i
Elderly more likely to wait in French ERs: study
NEW YORK (Reuters Health) - People age 75 and older are more likely than younger patients to wait longer than they should in emergency rooms, according to a new study from France. The study's lead author cautioned, however, that the finding doesn't mean
Some morning-after over-counter pill sales allowed
NEW YORK -- A New York appeals court is allowing some emergency contraception pills to be sold without a prescription or age restrictions while the government argues the issue in court. The 2nd U.S. Circuit Court of Appeals in Manhattan issued a brief or
FDA wins temporary halt on some morning-after pills
NEW YORK (Reuters) - The U.S. Food and Drug Administration on Wednesday won a temporary halt to part of a court order directing it to make emergency contraception available to girls over the counter. The 2nd U.S. Circuit Court of Appeals in New York said
Celgene's Revlimid wins additional FDA lymphoma approval
(Reuters) - Celgene Corp said on Wednesday that its flagship blood cancer drug, Revlimid, was approved by U.S. health regulators to treat mantle cell lymphoma, adding another revenue source for the $4 billion-a-year medicine. The U.S. Food and Drug Admin
Skipping shots at sick visits tied to vaccine delays
NEW YORK (Reuters Health) - Kids who don't get vaccines when they see their pediatrician for a sick visit - despite being due for the shots - are more likely to fall behind on immunizations and routine check-ups, according to a new study. "It's...
FDA panel revisits Avandia; likely too late for diabetes drug
(Reuters) - A panel of medical advisers to the U.S. Food and Drug Administration will revive a six-year-old debate over the safety of GlaxoSmithKline Plc's Avandia diabetes drug, but the two-day meeting that starts on Wednesday is not expected to greatly
Cadila Health to market new diabetes drug in India
MUMBAI (Reuters) - Drugmaker Cadila Healthcare Ltd received regulatory approval to market a new diabetes drug in India that it developed and is aiming for more than $1 billion in sales globally, the company said on Wednesday. Cadila, India's sixth-larges
Most read news
- 00:49 Saginaw Valley State University's longest-serving leader announces...
- 00:49 Descendants of message writer thrilled over discovery of bottle
- 00:48 Mauer, Doumit lead Twins over White Sox
- 00:48 Recap: Miami vs. San Antonio
- 00:38 Norwegian's Gem provides fast break from winter
- 00:35 Cougar on the hunt: Jennifer Aniston eyeing penthouse near NYU?
- 00:22 Uzbekistan cancels Valentine’s Day; Instead people can attend...
- 00:22 Detroit's huge fireworks show is changing sponsors, managing crowds...
- 00:22 Carolyn Hax: Man tells off ailing grandma of bride
- 00:19 Gov't report: Smooth launch unsure for health law
| « | ‹ | › | » | |||
| L | M | M | J | V | S | D |
| 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
